Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Mononucleosis Diagnostic Market Status and Forecast (2017-2028)
  • 1.3.2 Global Mononucleosis Diagnostic Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Mononucleosis Diagnostic Supply by Company

• 2.1 Global Mononucleosis Diagnostic Sales Value by Company
• 2.2 Mononucleosis Diagnostic Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Mononucleosis Diagnostic Market Status by Type

• 3.1 Mononucleosis Diagnostic Type Introduction
  • 3.1.1 Monospot Test
  • 3.1.2 Complete Blood Count Test
  • 3.1.3 Epstein Barr Virus (EBV) Antibody Test
• 3.2 Global Mononucleosis Diagnostic Market by Type
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Mononucleosis Diagnostic Market Status by Application

• 4.1 Mononucleosis Diagnostic Segment by Application
  • 4.1.1 Hospitals
  • 4.1.2 Laboratories
  • 4.1.3 Others
• 4.2 Global Mononucleosis Diagnostic Market by Application
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Mononucleosis Diagnostic Market Status by Region

• 5.1 Global Mononucleosis Diagnostic Market by Region
• 5.2 North America Mononucleosis Diagnostic Market Status
• 5.3 Europe Mononucleosis Diagnostic Market Status
• 5.4 Asia Pacific Mononucleosis Diagnostic Market Status
• 5.5 Central & South America Mononucleosis Diagnostic Market Status
• 5.6 Middle East & Africa Mononucleosis Diagnostic Market Status

6 North America Mononucleosis Diagnostic Market Status

• 6.1 North America Mononucleosis Diagnostic Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Mononucleosis Diagnostic Market Status

• 7.1 Europe Mononucleosis Diagnostic Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Mononucleosis Diagnostic Market Status

• 8.1 Asia Pacific Mononucleosis Diagnostic Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Mononucleosis Diagnostic Market Status

• 9.1 Central & South America Mononucleosis Diagnostic Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Mononucleosis Diagnostic Market Status

• 10.1 Middle East & Africa Mononucleosis Diagnostic Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Mononucleosis Diagnostic Market Forecast by Type and by Application

• 12.1 Global Mononucleosis Diagnostic Sales Value Forecast (2023-2028)
• 12.2 Global Mononucleosis Diagnostic Forecast by Type
• 12.3 Global Mononucleosis Diagnostic Forecast by Application

13 Global Mononucleosis Diagnostic Market Forecast by Region/Country

• 13.1 Global Mononucleosis Diagnostic Market Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Thermo Fischer Scientific
  • 14.1.1 Company Information
  • 14.1.2 Mononucleosis Diagnostic Product Introduction
  • 14.1.3 Thermo Fischer Scientific Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Siemens
  • 14.2.1 Company Information
  • 14.2.2 Mononucleosis Diagnostic Product Introduction
  • 14.2.3 Siemens Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Sekisui Diagnostics
  • 14.3.1 Company Information
  • 14.3.2 Mononucleosis Diagnostic Product Introduction
  • 14.3.3 Sekisui Diagnostics Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 Quidel Corporation
  • 14.4.1 Company Information
  • 14.4.2 Mononucleosis Diagnostic Product Introduction
  • 14.4.3 Quidel Corporation Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Meridian Bioscience
  • 14.5.1 Company Information
  • 14.5.2 Mononucleosis Diagnostic Product Introduction
  • 14.5.3 Meridian Bioscience Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.5.4 SWOT Analysis
• 14.6 Immunostics
  • 14.6.1 Company Information
  • 14.6.2 Mononucleosis Diagnostic Product Introduction
  • 14.6.3 Immunostics Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.6.4 SWOT Analysis
• 14.7 ELITechGroup
  • 14.7.1 Company Information
  • 14.7.2 Mononucleosis Diagnostic Product Introduction
  • 14.7.3 ELITechGroup Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.7.4 SWOT Analysis
• 14.8 Cardinal Health
  • 14.8.1 Company Information
  • 14.8.2 Mononucleosis Diagnostic Product Introduction
  • 14.8.3 Cardinal Health Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.8.4 SWOT Analysis
• 14.9 Bio-Rad Laboratories
  • 14.9.1 Company Information
  • 14.9.2 Mononucleosis Diagnostic Product Introduction
  • 14.9.3 Bio-Rad Laboratories Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.9.4 SWOT Analysis
• 14.10 Biomerieux
  • 14.10.1 Company Information
  • 14.10.2 Mononucleosis Diagnostic Product Introduction
  • 14.10.3 Biomerieux Mononucleosis Diagnostic Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.10.4 SWOT Analysis
• 14.11 Beckman Coulter
• 14.12 Abbott Laboratories

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Mononucleosis Diagnostic market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Mononucleosis Diagnostic industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Mononucleosis Diagnostic market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Mononucleosis Diagnostic Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Mononucleosis Diagnostic market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Mononucleosis Diagnostic Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Mononucleosis Diagnostic industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Monospot Test
Complete Blood Count Test
Epstein Barr Virus (EBV) Antibody Test

Segmented by Application
Hospitals
Laboratories
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Thermo Fischer Scientific
Siemens
Sekisui Diagnostics
Quidel Corporation
Meridian Bioscience
Immunostics
ELITechGroup
Cardinal Health
Bio-Rad Laboratories
Biomerieux
Beckman Coulter
Abbott Laboratories